The clinical observation of different therapeutic strategies in combined primary biliary cirrhosis and Sj(o)gren syndrome
10.3760/cma.j.issn.0578-1426.2012.11.005
- VernacularTitle:不同方案治疗原发性胆汁性肝硬化合并干燥综合征的临床研究
- Author:
Lixia GAO
;
Fengchun ZHANG
;
Li WANG
;
Xuan ZHANG
;
Bin LIU
- Publication Type:Journal Article
- Keywords:
Liver cirrhosis,biliary;
Sj(o)gren's syndrome;
Ursodeoxycholic acid;
Prednisonlone;
Azatharaprine
- From:
Chinese Journal of Internal Medicine
2012;51(11):851-854
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the role of different therapeutic regimens in primary biliary cirrhosis (PBC)complicating Sj(o)gren syndrome (SS).Methods A total of 79 patients diagnosed as PBC complicating SS were enrolled and randomly divided into three groups:Group U (29 patients) received ursodeoxycholic acid (UDCA) alone,Group UP (37 patients) received UDCA and prednisolone,Group UA (13 patients) received UDCA and azathioprine.The clinical and laboratory data were collected at 0,3,6 and 12 months after treatment.Results Fatigue and pruritus were improved in each group with no difference among them(P > 0.05).The levels of ALT,AST,alkaline phophatase (ALP),gamma-glutamyl transferase (GGT),TBil,DBil,IgG,and IgM in the three groups were all decreased after treatment(P <0.05),while there were no statistical differences among the three groups (P > 0.05).Conclusions The combination therapy of UDCA with prednisolone or azathioprine was not better than UDCA alone.The therapeutic policy of PBC complicating SS involved in the liver should settle PBC mainly.